4//SEC Filing
Young David 4
Accession 0000897069-25-000132
CIK 0001533743other
Filed
Jan 28, 7:00 PM ET
Accepted
Jan 29, 4:24 PM ET
Size
6.5 KB
Accession
0000897069-25-000132
Insider Transaction Report
Form 4
Young David
DirectorPres. Research & Development
Transactions
- Purchase
Common Stock
2025-01-27$0.80/sh+124,500$99,289→ 205,405 total
Holdings
- 18,544(indirect: By LLC)
Common Stock
- 30,985(indirect: By Trust)
Common Stock
- 10,786(indirect: By Family Entities)
Common Stock
Documents
Issuer
Processa Pharmaceuticals, Inc.
CIK 0001533743
Entity typeother
Related Parties
1- filerCIK 0001378166
Filing Metadata
- Form type
- 4
- Filed
- Jan 28, 7:00 PM ET
- Accepted
- Jan 29, 4:24 PM ET
- Size
- 6.5 KB